Endocrinology, Vol 137, 192-197, Copyright © 1996 by Endocrine Society

ARTICLES

Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I

J Yu, LY Xie and AB Abou-Samra
Endocrine Unit, Massachusetts General Hospital, Boston 02114, USA.

The hypothalamic-pituitary-adrenal axis is an essential physiological system in many species. CRF, the major neuropeptide regulating ACTH secretion, is highly conserved in its primary sequence. Evolutionary conservation of the CRF sequence suggests that the CRF receptor (CRF-R) complementary DNA and examined its properties. The avian CRF-R complementary DNA encodes a 420-amino acid protein that is 87-88% identical to those of human, rat, and mouse. Most sequence divergence occurs in the putative signal peptide and the extracellular amino- terminus of the receptor. Five additional amino acids are inserted in the amino-terminus of the cCRF-R. When expressed in COS-7 cells, the cCRF-R binds the CRF and urotensin I radioligands with high affinities. Urotensin I competes for binding to the chicken CRF-R, expressed in COS- 7 cells, with an apparent affinity 20 times higher than that of CRF. Both urotensin I and sauvagine were more effective in stimulating cAMP accumulation in COS-7 cells transfected with the cCRF-R than CRF. The effects of CRF and urotensin I on inositol phosphate accumulation were also tested. Urotensin I was an effective as CRF in stimulating inositol phosphate accumulation in COS-7 cells transfected with the cCRF-R. These data suggest that the sequence of the CRF-R is highly conserved from avian to mammalian species and that, despite its high sequence homology to the type A mammalian CRF-R, the ligand binding properties of cCRF-R are similar to those of the type B CRF-R i.e. a higher affinity for urotensin I than for CRF.

This article has been cited by other articles:

				M. V. Mikhailova, P. R. Mayeux, A. Jurkevich, W. J. Kuenzel, F. Madison, A. Periasamy, Y. Chen, and L. E. Cornett Heterooligomerization between Vasotocin and Corticotropin-Releasing Hormone (CRH) Receptors Augments CRH-Stimulated 3',5'-Cyclic Adenosine Monophosphate Production Mol. Endocrinol., September 1, 2007; 21(9): 2178 - 2188. [Abstract] [Full Text] [PDF]

				K. Vandenborne, B. De Groef, S. M E Geelissen, E. R Kuhn, V. M Darras, and S. Van der Geyten Corticosterone-induced negative feedback mechanisms within the hypothalamo-pituitary-adrenal axis of the chicken J. Endocrinol., June 1, 2005; 185(3): 383 - 391. [Abstract] [Full Text] [PDF]

				B. De Groef, N. Goris, L. Arckens, E. R. Kuhn, and V. M. Darras Corticotropin-Releasing Hormone (CRH)-Induced Thyrotropin Release Is Directly Mediated through CRH Receptor Type 2 on Thyrotropes Endocrinology, December 1, 2003; 144(12): 5537 - 5544. [Abstract] [Full Text] [PDF]

				M. H. Perrin, M. R. DiGruccio, S. C. Koerber, J. E. Rivier, K. S. Kunitake, D. L. Bain, W. H. Fischer, and W. W. Vale A Soluble Form of the First Extracellular Domain of Mouse Type 2beta Corticotropin-releasing Factor Receptor Reveals Differential Ligand Specificity J. Biol. Chem., April 25, 2003; 278(18): 15595 - 15600. [Abstract] [Full Text] [PDF]

				R. L. Hauger, D. E. Grigoriadis, M. F. Dallman, P. M. Plotsky, W. W. Vale, and F. M. Dautzenberg International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands Pharmacol. Rev., March 1, 2003; 55(1): 21 - 26. [Abstract] [Full Text] [PDF]

				I. Assil-Kishawi and A. B. Abou-Samra Sauvagine Cross-links to the Second Extracellular Loop of the Corticotropin-releasing Factor Type 1 Receptor J. Biol. Chem., August 30, 2002; 277(36): 32558 - 32561. [Abstract] [Full Text] [PDF]

				I. Q. Assil and A. B. Abou-Samra N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1015 - E1021. [Abstract] [Full Text] [PDF]

				B. A. Hofmann, S. Sydow, O. Jahn, L. Van Werven, T. Liepold, K. Eckart, and J. Spiess Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1 Protein Sci., October 19, 2001; 10(10): 2050 - 2062. [Abstract] [Full Text] [PDF]

				M. H. PERRIN and W. W. VALE Corticotropin Releasing Factor Receptors and Their Ligand Family Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 312 - 328. [Abstract] [Full Text] [PDF]

				A. Ruhmann, I. Bonk, C. R. Lin, M. G. Rosenfeld, and J. Spiess Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2beta -selective antisauvagine-30 PNAS, December 22, 1998; 95(26): 15264 - 15269. [Abstract] [Full Text] [PDF]

				F. M. Dautzenberg, S. Wille, R. Lohmann, and J. Spiess Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: Implications for the ligand-binding site PNAS, April 28, 1998; 95(9): 4941 - 4946. [Abstract] [Full Text] [PDF]

				A. Iida-Klein, J. Guo, M. Takemura, M. T. Drake, J. T. Potts Jr., A. Abou-Samra, F. R. Bringhurst, and G. V. Segre Mutations in the Second Cytoplasmic Loop of the Rat Parathyroid Hormone (PTH)/PTH-related Protein Receptor Result in Selective Loss of PTH-stimulated Phospholipase C Activity J. Biol. Chem., March 14, 1997; 272(11): 6882 - 6889. [Abstract] [Full Text] [PDF]

				M. H. Perrin, W. H. Fischer, K. S. Kunitake, A. G. Craig, S. C. Koerber, L. A. Cervini, J. E. Rivier, J. C. Groppe, J. Greenwald, S. M. Nielsen, et al. Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor Receptor J. Biol. Chem., August 17, 2001; 276(34): 31528 - 31534. [Abstract] [Full Text] [PDF]